CEBP  Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, K.-M.
Right arrow Articles by Kang, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, K.-M.
Right arrow Articles by Kang, D.
Cancer Epidemiology Biomarkers & Prevention Vol. 14, 821-825, April 2005
© 2005 American Association for Cancer Research

Genetic Polymorphisms of Ataxia Telangiectasia Mutated and Breast Cancer Risk

Kyoung-Mu Lee1,3, Ji-Yeob Choi1, Sue Kyung Park5, Hye-Won Chung6, Byungchan Ahn7, Keun-Young Yoo1, Wonshik Han2, Dong-Young Noh2, Sei-Hyun Ahn4, Ho Kim3, Qingyi Wei8 and Daehee Kang1

Departments of 1 Preventive Medicine and 2 Surgery, Cancer Research Institute, College of Medicine, 3 Graduate School of Public Health, Seoul National University, Seoul, Korea; 4 Department of Surgery, Ulsan University College of Medicine, Seoul, Korea; 5 Department of Preventive Medicine, Kon-Kuk University College of Medicine, Chungcheongbuk-Do, Korea; 6 Department of Obstetrics and Gynecology, Ewha Womans University College of Medicine, Seoul, Korea; 7 Microbiology and Genetic Engineering, College of Natural Science, Ulsan University, Ulsan, Korea; and Department of 8 Epidemiology-189, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas

Requests for reprints: Daehee Kang, Department of Preventive Medicine, Seoul National University College of Medicine, 28 Yongon-Dong Chongno-Gu, Seoul 110-799, Korea. Tel: 822-740-8326; Fax: 822-747-4830. E-mail: dhkang{at}snu.ac.kr

To evaluate the role of genetic polymorphisms of ataxia telangiectasia mutated (ATM) in the etiology of breast cancer, a hospital-based case-control study was conducted in Korea. Nine-hundred ninety-six histologically confirmed incident breast cancer cases and 1,181 cancer-free controls were recruited in Seoul between 1995 and 2003. Genotypes of the ATM polymorphisms-5144A>T, IVS21+1049T>C, IVS33–55T>C, IVS34+60G>A, and 3393T>G were determined by the 5'-nuclease assay. Individual haplotypes were estimated from genotype data by a Bayesian method. Five ATM alleles were found to be in strong linkage disequilibrium (D' > 0.82; P < 0.001). Haplotype frequencies were significantly different between cases and controls ({chi}2 test, P < 0.001). The ATM IVS21+1049 TC or CC, IVS34+60 GA or AA, and 3393 TG or GG genotypes were associated with increased breast cancer risk, particularly in premenopausal women [odds ratios (OR), 1.51; 95% confidence interval (CI), 1.11-2.05; OR, 1.42; 95% CI, 1.08-1.88; and OR, 1.37; 95% CI, 1.04-1.80, respectively]. Compared with diploid of TCCAG:TCCAG, the most common haplotype, the ATTGT:ATTGT was associated with decreased risk of breast cancer with borderline significance (OR, 0.77; 95% CI, 0.58-1.04) and TCCAG:ATCGT and ATTGT:ACCAG were associated with increased breast cancer risk (OR, 2.30; 95% CI, 1.18-4.48 and OR, 2.43; 95% CI, 1.1.07-5.52, respectively) after adjusting for age, education, age at first full-term pregnancy, parity, family history of breast cancer, alcohol consumption, and smoking. As the number of ATTGT haplotype decreased, the risk of breast cancer increased (P for trend <0.01). Our results thus suggest that genetic polymorphisms of ATM play an important role in the development of breast cancer in Korean women.




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
H.-M. Hsu, H.-C. Wang, S.-T. Chen, G.-C. Hsu, C.-Y. Shen, and J.-C. Yu
Breast Cancer Risk Is Associated with the Genes Encoding the DNA Double-Strand Break Repair Mre11/Rad50/Nbs1 Complex
Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 2024 - 2032.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
The Breast Cancer Association Consortium
Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium.
J Natl Cancer Inst, October 4, 2006; 98(19): 1382 - 1396.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
Z. Hu, M. Shao, J. Yuan, L. Xu, F. Wang, Y. Wang, W. Yuan, J. Qian, H. Ma, Y. Wang, et al.
Polymorphisms in DNA damage binding protein 2 (DDB2) and susceptibility of primary lung cancer in the Chinese: a case-control study
Carcinogenesis, July 1, 2006; 27(7): 1475 - 1480.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
J. H. Kim, H. Kim, K. Y. Lee, K.-H. Choe, J.-S. Ryu, H. I. Yoon, S. W. Sung, K.-Y. Yoo, and Y.-C. Hong
Genetic polymorphisms of ataxia telangiectasia mutated affect lung cancer risk
Hum. Mol. Genet., April 1, 2006; 15(7): 1181 - 1186.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2005 by the American Association for Cancer Research.